Interestingly, inconsistencies with the treatment guidelines were found in 58.3% of all patients with heart failure, especially regarding the lack of the most advisable treatment strategy, which can have an impact on final patient-survival (e.g. β-blockers and ACE-inhibitors or ARBs) [19]. This evidence concerns the gene ACE and heart failure.